UnitedHealth Group has been upgraded to a Zacks Rank #1, or Strong Buy, driven by a significant upward revision in its earnings estimates. The consensus estimate for the current quarter has risen 8.1% over the last 30 days to $3.90 per share, with four analysts raising their forecasts against one lowering. For the full year, the estimate has climbed 7.29% to $19.23 per share, supported by nine positive revisions and no negative ones. The stock has gained 6.6% over the past four weeks, reflecting investor confidence in the improving outlook for the largest U.S. health insurer.
UnitedHealth Group IncorporatedUpgraded to Zacks Rank #1 (Strong Buy) on rising earnings estimates, with multiple analyst revisions upward.